- Clinical Trials
- November 2024
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Report
- May 2024
- 128 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- May 2024
- 133 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- May 2024
- 132 Pages
Global
From €3502EUR$3,999USD£3,040GBP
Famvir is an antiviral drug used to treat infections caused by certain types of viruses. It is used to treat infections caused by herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus. It is also used to treat shingles, cold sores, and chickenpox. Famvir is part of the Infectious Diseases Drugs market, which includes drugs used to treat a wide range of infectious diseases, including bacterial, viral, fungal, and parasitic infections. These drugs are used to treat a variety of conditions, including pneumonia, meningitis, HIV/AIDS, and malaria.
The Famvir market is highly competitive, with a number of companies offering similar products. Some of the major players in the market include GlaxoSmithKline, Novartis, Merck, Pfizer, and Sanofi. Other companies in the market include AstraZeneca, Bristol-Myers Squibb, and Johnson & Johnson. Show Less Read more